Hampshire Hospitals NHS Foundation Trust has marked the first anniversary of becoming the UK's first NHS trust to introduce Intuitive's da Vinci 5 surgical robot, logging more than 450 procedures since November 2025. The milestone, reported by Newbury Today, covers work performed at Basingstoke and North Hampshire Hospital.
What has the da Vinci 5 actually been used for?
The system has been deployed across multiple surgical specialties, including hepatobiliary and cancer surgery, using minimally invasive techniques for procedures that would previously have required open surgery. Consultant surgeon Pulkit Sethi, who performed the trust's initial cases, said the team has made \"significant progress in establishing our robotic surgery programme, successfully delivering advanced surgical care.\"
How was the program funded, and who benefits?
The da Vinci 5 was funded through a charitable partnership between Hampshire Hospitals Charity and the Hampshire Medical Fund, rather than through core NHS capital budgets, a funding route increasingly common for NHS trusts trying to adopt expensive robotic platforms without waiting on national procurement cycles. Tim Moore, the trust's medical director for surgery, said the \"improved outcomes the surgical robot has helped us achieve over the last 12 months has been fantastic,\" citing shorter hospital stays and faster recovery as the clearest benefits for patients.
Why does one hospital's robot count matter nationally?
More than 450 operations in a single year at one trust is a meaningful adoption rate for a platform that only reached its first UK hospital 12 months ago. It gives NHS administrators elsewhere a concrete throughput benchmark to weigh against the cost of the da Vinci 5, which sits at the high end of Intuitive's product line and competes for NHS budgets against newer entrants like CMR Surgical's Versius and Medtronic's Hugo, the latter of which just won FDA clearance for general surgery in the US. Charitable co-funding models like Hampshire's could become a template other trusts use to get robotic platforms installed faster than waiting for centralized NHS capital allocation.
What comes next for the program?
The trust has not announced specific targets for year two, but the current trajectory, averaging more than 37 procedures a month, suggests Hampshire intends to expand the range of operations performed on the platform rather than plateau. With cancer and hepatobiliary cases already running on the system, the next test will be whether the trust extends robotic-assisted surgery into additional specialties such as colorectal or gynaecological procedures, areas where other NHS trusts have already built out da Vinci programs.